We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 547 results
  1. New Antiviral Agent for Influenza: Baloxavir

    It is estimated that a billion cases of influenza occur each year globally and that three to five million are serious infections with annual...
    Chapter 2023
  2. Gut dysbiosis induces the development of mastitis through a reduction in host anti-inflammatory enzyme activity by endotoxemia

    Background

    Mounting experimental evidence has shown that the gut microbiota plays a significant role in the pathogenesis of mastitis, and clinical...

    Caijun Zhao, **aoyu Hu, ... Yunhe Fu in Microbiome
    Article Open access 01 December 2022
  3. Sialic acid exacerbates gut dysbiosis-associated mastitis through the microbiota-gut-mammary axis by fueling gut microbiota disruption

    Background

    Mastitis is one of the most severe diseases in humans and animals, especially on dairy farms. Mounting evidence indicates that...

    Caijun Zhao, **aoyu Hu, ... Yunhe Fu in Microbiome
    Article Open access 17 April 2023
  4. Genetic and virological characteristics of a reassortant avian influenza A H6N1 virus isolated from wild birds at a live-bird market in Egypt

    The first detection of a human infection with avian influenza A/H6N1 virus in Taiwan in 2013 has raised concerns about this virus. During our routine...

    Omnia Kutkat, Mokhtar Gomaa, ... Rabeh El-Shesheny in Archives of Virology
    Article 09 April 2024
  5. Thiourea Catalysts for Synthesis of Active Pharmaceutical Ingredients

    Thiourea is an important building block found in several drug molecules such as thioacetazone, enzalutamide, and thiocarlide. Thiourea derivatives...
    Sharada Prasanna Swain, Kankanala Naveen Kumar, V. Ravichandiran in Recent Advances in Pharmaceutical Innovation and Research
    Chapter 2023
  6. Comparative pathogenic potential of avian influenza H7N3 viruses isolated from wild birds in Egypt and their sensitivity to commercial antiviral drugs

    Active surveillance and studying the virological features of avian-origin influenza viruses are essential for early warning and preparedness for the...

    Ahmed E. Kayed, Omnia Kutkat, ... Mohammed A. Ramadan in Archives of Virology
    Article 09 February 2023
  7. Influenza A Virus Neuraminidase Inhibitors

    Depending on the strain, influenza A virus causes animal, zoonotic, pandemic, or seasonal influenza with varying degrees of severity. Two surface...
    Nongluk Sriwilaijaroen, Christopher J. Vavricka, ... Yasuo Suzuki in Glycovirology
    Protocol 2022
  8. Assays for Determining the Sialidase Activity of Influenza Viruses and Monitoring Influenza Virus Susceptibility to Neuraminidase Inhibitors

    Three types of assays––colorimetric, fluorescent, and chemiluminescent––are used to determine the sialidase (neuraminidase: NA) activity of influenza...
    Emi Takashita in Glycovirology
    Protocol 2022
  9. Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan

    Background

    We aimed to evaluate the factors associated with baloxavir prescription in Japanese hospitals using a health insurance claim-based database...

    Naomi Fujiwara, Takashi Fujiwara, Yuya Ise in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 01 February 2023
  10. Enzymatic Substrates and Fluorescence Imaging of Influenza Virus Sialidase

    Immunostaining with an antiviral antibody is usually performed to visualize virus-infected cells. In contrast, this study established an easy method...
    Yuuki Kurebayashi, Tadanobu Takahashi, Takashi Suzuki in Glycovirology
    Protocol 2022
  11. Antivirals: Approaches and the Way Forward

    Viral diseases pose significant challenges in human and veterinary medicine, as effective treatment options are limited. The development of antiviral...
    Adarsh Mishra, Inderpal Kaur, ... Yashpal Singh Malik in Advances in Antiviral Research
    Chapter 2024
  12. Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice

    Seasonal influenza virus remains a common cause of mortality despite the use of neuraminidase inhibitors. This study evaluated the efficacy of a...

    Andrew C. Y. Lee, Kelvin K. W. To, ... Kwok-Yung Yuen in Archives of Virology
    Article 07 May 2018
  13. Antiviral Agents

    The viruses, unlike most bacteria, are obligate intracellular pathogens that use biosynthesis mechanisms and enzymes of the host cells for...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
  14. Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea

    Background

    The emergence of influenza viruses resistant to anti-influenza drugs is a threat to global public health. The Korea Centers for Disease...

    Heui Man Kim, Namjoo Lee, ... Yoon-Seok Chung in Virology Journal
    Article Open access 06 July 2020
  15. Anti-Influenza Activity of Cetraria islandica Lichen Extracts in In Vitro Experiments

    The toxicity and antiviral activity of extracts obtained by the methods of aqueous and ethanol extraction of bioactive substances from Cetraria...

    E. V. Makarevich, E. I. Filippova, ... N. A. Mazurkova in Bulletin of Experimental Biology and Medicine
    Article 01 June 2023
  16. Synthesis and Neuraminidase Inhibitory Activity of Sialic Acid Analogues with Fluoro, Phosphono, and Sulfo Functionalities

    Methods to synthesize influenza virus inhibitors with fluoro, phosphono, and/or sulfo functional groups are described. The resulting sialic acid...
    Christopher J. Vavricka, Nongluk Sriwilaijaroen, ... Hiromasa Kiyota in Glycovirology
    Protocol 2022
  17. Human infection with a reassortant swine-origin influenza A(H1N2)v virus in Taiwan, 2021

    Background

    Influenza A virus infections occur in different species, causing mild-to-severe symptoms that lead to a heavy disease burden. H1N1, H1N2...

    Ji-Rong Yang, Chuan-Yi Kuo, ... Ming-Tsan Liu in Virology Journal
    Article Open access 07 April 2022
  18. An Updated Review on Influenza Viruses

    Influenza virus is a highly contagious respiratory virus also known as seasonal flu. This virus belongs to the Orthomyxoviridae family and its genome...
    Unnati Bhalerao, Anil Kumar Mavi, ... Vishwajeet Rohil in Emerging Human Viral Diseases, Volume I
    Chapter 2023
  19. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts

    Background

    Human infection with avian influenza H7N9 virus was first reported in 2013. Since the fifth epidemic, a highly pathogenic avian influenza...

    **g Tang, **g Zhang, ... Dayan Wang in Virology Journal
    Article Open access 02 July 2019
  20. In Ovo-Based Antiviral Assay for Screening of Herbal Formulations Against Influenza Viruses

    Multiple formats of in vitro tests and in vivo models enable us to test and screen existing antiviral drugs as well as discover new drugs....
    Suresh Samadhan Ghoke, Richa Sood, ... Sandeep Bhatia in Advances in Antiviral Research
    Chapter 2024
Did you find what you were looking for? Share feedback.